https://www.marketscreener.com/quote/stock/PAION-AG-462044/news/Paion-Submits-Extension-Application-of-Marketing-Authorization-for-Remimazolam-in-the-Indication-Gen-37450036/?utm_source=telegram&utm_medium=social&utm_campaign=share